GF was 27% versus 4% CI of neutrophil engraftment was 61.9% versus 94.4%, ()
(i) 5 patients were desensitized and 3/5 engrafted (ii) 67, 5, and 7 patients were antibody-negative, non-DSA-positive, and DSA-positive after desensitization
GF was 18.2% and 57% in patients who had DSAs against 1 and 2 UCB, respectively, versus 5.5% in patients without DSAs ()
The rates of death or relapse within 100 days for the group of patients without DSAs, with DSAs against a single UCB unit, or DSAs against both UCB units were 23.6%, 36.4%, and 71.4%, respectively ()